← Leaderboards
Xianlin Han
Washington University
$13,463,600
Attributed
$15,975,565
Total exposure
26
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,975,565 · 26
By mechanism
R01$8,211,702 · 5
RF1$5,270,574 · 2
P30$802,659 · 3
P01$801,117 · 1
R56$543,533 · 1
P41$345,980 · 14
Top collaborators
- Lizhen Chen2 shared
- Jeffrey L. Dupree2 shared
- Sudha Seshadri1 shared
Most similar at Washington University
Same institution · by research overlap
- Dabeeru C Rao$40,181,778
- Mohamed A. Zayed$7,854,663
- Clay F. Semenkovich$38,041,096
- Guojun Bu$30,610,787
- Thomas Edward Conturo$5,582,547
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposLipidsS DiseaseMolecularBrainResearch PersonnelPlayInsightSamplingNerve DegenerationFundingLipid MetabolismPathogenesisPathologySulfoglycosphingolipidsEarly DiagnosisDementiaShotgunsMass SpectrometryBiochemicalMyelinCerebrospinal FluidAgingLink
Grant awards (56)
Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimerâs disease$622,837
R01 · FY2025 · AG · contact PI
The role of sulfatide in the development of tauopathy in the context of ADRD$602,040
R01 · FY2025 · AG · contact PI
GeroMetabolism Core$216,562
P30 · FY2025 · AG · contact PI
Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimerâs disease$635,549
R01 · FY2024 · AG · contact PI
The role of sulfatide in the development of tauopathy in the context of ADRD$628,702
R01 · FY2024 · AG · contact PI
Integrated Physiology of Aging Core (IPAC)$176,229
P30 · FY2024 · AG · contact PI
South Texas Alzheimerâs Disease Center Biomarker Core$102,467
P30 · FY2024 · AG · contact PI
South Texas Alzheimerâs Disease Center Biomarker Core$102,467
P30 · FY2023 · AG · contact PI
South Texas Alzheimerâs Disease Center Biomarker Core$102,467
P30 · FY2022 · AG · contact PI
Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimerâs disease$1,887,634
RF1 · FY2021 · AG · contact PI
South Texas Alzheimerâs Disease Center Biomarker Core$102,467
P30 · FY2021 · AG · contact PI
Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimerâs disease$543,533
R56 · FY2019 · AG · contact PI
Identification of a missing key element underlying apoE2 neuroprotection in Alzheimer's disease and the aging brain$3,382,940
RF1 · FY2018 · AG · contact PI
Identification of altered lipids predictive of anesthetic-induced brain injury$301,238
R01 · FY2016 · GM · contact PI
Identification of altered lipids predictive of anesthetic-induced brain injury$88,479
R01 · FY2016 · GM · contact PI
Identification of altered lipids predictive of anesthetic-induced brain injury$414,375
R01 · FY2015 · GM · contact PI
Identification of altered lipids predictive of anesthetic-induced brain injury$212,500
R01 · FY2015 · GM · contact PI
Identification of altered lipids predictive of anesthetic-induced brain injury$414,375
R01 · FY2014 · GM · contact PI
Identification of altered lipids predictive of anesthetic-induced brain injury$414,375
R01 · FY2013 · GM · contact PI
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases$662,780
R01 · FY2011 · AG · contact PI
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases$513,637
R01 · FY2010 · AG · contact PI
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases$20,000
R01 · FY2010 · AG · contact PI
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases$526,844
R01 · FY2009 · AG · contact PI
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases$536,188
R01 · FY2008 · AG · contact PI
THE ROLE OF SULFATIDES IN ALZHEIMER'S DISEASE$262,303
R01 · FY2008 · AG · contact PI
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases$529,887
R01 · FY2007 · AG · contact PI
THE ROLE OF SULFATIDES IN ALZHEIMER'S DISEASE$267,657
R01 · FY2007 · AG · contact PI
SHOTGUN LIPIDOMICS OF PHOSPHOETHANOLAMINE-CONTAINING LIPIDS IN BIOLOGICAL$2,824
P41 · FY2007 · RR · contact PI
SHOTGUN LIPIDOMICS: ELECTROSPRAY IONIZATION MASS SPECTROMETRIC ANALYSIS$2,824
P41 · FY2007 · RR · contact PI
SHOTGUN LIPIDOMICS IDENTIFIES CARDIOLIPIN DEPLETION IN DIABETIC MYOCARDIUM$2,824
P41 · FY2007 · RR · contact PI
SHOTGUN LIPIDOMICS OF CARDIOLIPIN MOLECULAR SPECIES IN LIPID EXTRACTS$2,824
P41 · FY2007 · RR · contact PI
FACTORS INFLUENCING THE ELECTROSPRAY INTRASOURCE SEPARATION$2,824
P41 · FY2007 · RR · contact PI
CORE--CHEMISTRY$378,303
P01 · FY2006 · HL · contact PI
THE ROLE OF SULFATIDES IN ALZHEIMER'S DISEASE$275,651
R01 · FY2006 · AG · contact PI
CORE--CHEMISTRY$368,938
P01 · FY2005 · HL
THE ROLE OF SULFATIDES IN ALZHEIMER'S DISEASE$282,285
R01 · FY2005 · AG
CSF SULFATIDE IS DECREASED IN INDIVIDUALS W/ MILD COGNITIVE IMPAIRMENT/ DEMENTI$649
P41 · FY2005 · RR
NOVEL ROLE FOR APOLIPOPROTEIN E IN CENTRAL NERVOUS SYSTEM, MODOF SULCONTENT$649
P41 · FY2005 · RR
LIPIDOMICS OF LIPID RAFTS: MASS SPECT$649
P41 · FY2005 · RR
QUANTITATIVE ANALYSIS OF CELLULAR TRIACYLGLYCERIDES DIRECTLY FROM CRUDE SAMPLE$649
P41 · FY2005 · RR
QUANTIFY CERAMIDE MOLECULAR SPECIES FROM LIPID EXTRACTS OF BIOL SAMPLES BY MS$649
P41 · FY2005 · RR
TRIGLYCERIDE ACCUMULATION PROTECTS AGAINST FATTY ACID INDUCED LIPOTOXICITY$649
P41 · FY2005 · RR
SUBSTANTIAL SULFATIDE DEFICIENCY &CERAMIDE ELEVATION IN VERY EARLY ALZHEIMERS$649
P41 · FY2005 · RR
CELLULAR LIPIDOMES FROM CRUDE EXTRACTS OF BIOL SAMPLES BY MS$649
P41 · FY2005 · RR
QUANTIFY CERAMIDE MOLECULAR SPECIES FROM LIPID EXTRACTS OF BIOL SAMPLES BY MS$804
P41 · FY2004 · RR
SUBSTANTIAL SULFATIDE DEFICIENCY &CERAMIDE ELEVATION IN VERY EARLY ALZHEIMERS$804
P41 · FY2004 · RR
CELLULAR LIPIDOMES FROM CRUDE EXTRACTS OF BIOL SAMPLES BY MS$804
P41 · FY2004 · RR
CSF SULFATIDE IS DECREASED IN INDIVIDUALS W/ MILD COGNITIVE IMPAIRMENT/ DEMENTIA$804
P41 · FY2004 · RR
NOVEL ROLE FOR APOLIPOPROTEIN E IN CENTRAL NERVOUS SYSTEM$804
P41 · FY2004 · RR
LIPIDOMICS OF LIPID RAFTS: MASS SPECT$804
P41 · FY2004 · RR
QUANTITATIVE ANALYSIS OF CELLULAR TRIACYLGLYCERIDES DIRECTLY FROM CRUDE SAMPLE$804
P41 · FY2004 · RR
MEMBRANE FUSION PANCREATIC ISLET SECRETORY GRANULES &PLASMA MEMBRANES CATALYSIS$157,506
P41 · FY2002 · RR
CORE--CHEMISTRY$26,938
P01 · FY2002 · HL
MEMBRANE FUSION PANCREATIC ISLET SECRETORY GRANULES &PLASMA MEMBRANES CATALYSIS$157,506
P41 · FY2001 · RR
CORE--CHEMISTRY$26,938
P01 · FY2000 · HL
MEMBRANE FUSION PANCREATIC ISLET SECRETORY GRANULES &PLASMA MEMBRANES CATALYSIS$6,028
P41 · FY2000 · RR